|
|
 | | | |
- close
- close
- close
- close
Acura Pharmaceuticals (ACUR) |
StreetInsider.com
Apr 17
Comment
Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) 28% HIGHER; news the FDA blocked old OxyContin generics from coming to the market.
E2open (NASDAQ: EOPN) 27% LOWER; reported Q4 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue...
StreetInsider.com
Mar 6
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/Acura+Pharma+%28ACUR%29+Files+%2475M+Mixed+Shelf/8163021.html for the full story.
Benzinga
Mar 5
Comment
Shares of small-cap name Acura Pharmaceuticals (NASDAQ: ACUR) were among the leaders on the Nasdaq on Tuesday after the company announced that the Kerr Drug store chain will carry Acura's Nexafed drug. The product is a decongestant which is...
Benzinga
Mar 5
Comment
Acura Pharmaceuticals (NASDAQ: ACUR) shares advanced 51.22% to $3.10 at 10:18 am. Acura reported a Q4 net loss of $3 million.
Zoltek Companies (NASDAQ: ZOLT) surged 22.32% to $11.31. The Quinpario Group disclosed aggregate ownership of around...
StreetInsider.com
Mar 4
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Acura+Pharmaceuticals%2C+Inc.+%28ACUR%29+Reports+Q4+Loss+of+%240.86Share/8153104.html for the full story.
StreetInsider.com
Dec 20
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Acura+Pharma+%28ACUR%29+Submits+IND+for+Hydrocodone+Bitartrate+Testing/7962625.html for the full story.
Benzinga
Dec 12
Comment
Shares of small-cap biotech company Acura Pharmaceuticals (NASDAQ: ACUR) soared once again on Tuesday after a massive rally in the name during Monday's trading session. The stock surged 42 percent and closed the day at $3.49. Acura opened the...
Benzinga
Dec 11
Comment
Below are highlights from Benzinga's daily coverage of small cap securities making big moves:
Acura Pharmaceuticals
Shares of Acura Pharmaceuticals (NASDAQ: ACUR), the Palatine, IL specialty pharmaceutical company, rose 71% Monday on 34...
Benzinga
Dec 10
Comment
A press release on Monday morning has sent shares of Acura Pharmaceuticals (NASDAQ: ACUR) sharply higher during the trading session. At last check, the stock had added around 64 percent and was trading at $2.36. The company announced the release...
Forbes
Dec 10
Comment
The Palantine, Illinois-based company, Acura Pharmaceuticals, today launched a new nasal decongestant product formulated to prevent its use in the illicit synthesis of methamphetamine.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
